Modular endoprostheses can be used to reconstruct large osseous defects resulting from tumor resection, trauma, revision arthroplasty, or other causes. They historically have used polymethylmethacrylate cement for fixation to host bone. Newer designs incorporating stems that use cementless bone-ingrowth surfaces have become available, but it is not clear how these compare with cemented designs.
INTRODUCTION
M odular endoprostheses can be used to reconstruct bone defects resulting from a tumor resection, a metastatic lesion, failed internal fixation, nonunion, or failed total hip or knee arthroplasty. 1--3 Other techniques available include osteoarticular allografts and allograft prosthetic composites; however, long-term results with these techniques have been less predictable. 4--8 Most current prosthesis designs rely on polymethylmethacrylate (PMMA) bone cement for fixation to the host bone. 9 Early cementless designs had a high rate of failure related to stem breakage and loosening. 10, 11 Newer cementless designs have become available, and some have begun to use these stems in a select group of patients treated with modular endoprosthetic reconstruction.
Most implanted modular endoprostheses rely on PMMA cement for fixation. 9 The experience of using routine arthroplasty with standard cemented femoral and tibial components has in general been acceptable, 12, 13 with overall low revision rates. 14 The long-term durability of cemented modular endoprostheses has not been as reliable, with revision rates of up to 69% at 10 years. 15 The most common mode of failure leading to revision surgery is aseptic loosening, which has been reported to account for up to 44% of revisions of modular endoprostheses. 15--21 This high rate of failure, and aseptic loosening in particular, may be caused by the unique biomechanical demands on reconstructions of large osseous defects. Aseptic loosening can be the result of macrophage mediated osteolysis stimulated by particular wear debris or of mechanical failure of the implant-bone interface. 22 In addition, the length of the prosthesis increases the mechanical stress borne by the bone-cement or bone-implant interface. 23 Implants with larger bone resections, and therefore longer implants, have been shown to have a higher rate of failure. 23, 24 When large bone defects are reconstructed, the implants used often are cemented into relatively smooth diaphyseal bone, which may result in a weak bone--cement interface. 25 Other potential mechanisms of failure include loosening from particle wear debris and osteolysis, infection, or periprosthetic fracture or stem breakage. 11, 16, 19, 21 In proximal femoral replacements, hip dislocation and recurrent instability are unique modes of failure. 26 In an attempt to increase the strength of the implant-bone interface, and to create a more durable bond, cementless designs have become available. Cementless stems have the advantage of allowing bone-ingrowth and therefore a dynamic bond that can respond over time to the stresses placed upon it. 27 Bone ingrowth, however, is dependent upon numerous mechanical and biologic factors. While the experience in routine arthroplasty has been positive, the unique problems associated with oncology patients, as well as the poorly understood effects of radiation and chemotherapy on bone ingrowth, lead to uncertainty as to whether or not cementless steams are an appropriate choice for this population.
Early cementless stem designs have had a high failure rate related to stem breakage. 10, 11 Osteolysis and aseptic loosening also led to failure in up to 27% of patients. 28 These results were based on the use of stems designed and implanted during the 1980s. Newer designs have recently become available, and the short-term results of these contemporary prostheses are beginning to be defined. We present a series of 127-mm straight cementless stems in the reconstruction of large osseous defects of the lower extremity in 37 patients. The goal of our study was to define shortterm results with this technique and particular stem type.
MATERIALS AND METHODS
We performed a retrospective review of all consecutive patients who had endoprosthetic reconstruction of the proximal femur, distal femur, or proximal tibia using cementless fixation at our institution from January, 2002 through December, 2007. Before the study, approval was obtained from our Institutional Review Board (IRB). Patients treated with modular endoprosthetic reconstruction were identified through use of our electronic orthopaedic oncology database as well as billing records. All patients treated with modular endoprosthetic reconstruction using 127-mm straight-stem cementless and modern surgical technique were included in the study. Thirty-seven patients were identified and no patients were excluded.
The population included in this study represented a portion of the total number of modular endoprostheses used in the treatment of large osseous defects at our institution. We used both cemented and cementless prostheses, as well as allografts and allograft prosthetic composites as part of our clinical practice. The decision to use a cementless modular megaprosthesis was made by the operating surgeon and was multifactorial. Patient age, perceived bone quality, diagnosis, prognosis, and the use of adjuvant therapies including radiation and chemotherapy were considered.
In all patients, the implants used were the Global Modular Replacement System with a 127-mm straight cementless stem (GMRS, Stryker, Kalamazoo, MI; Figure 1 ). We chose one particular stem to include in this study because it was the most frequently used stem in our recent cases, and these stems were inserted by all surgeons using a standardized reconstruction technique. After resection of the tumor or removal of the previously failed implant, the diaphyseal canal was prepared. The bone end was cut perpendicular to its long axis and face reamed, leaving a clean and even surface. A prophylactic cerclage wire was placed around the end of the bone to prevent fracture. The canal was then prepared by sequential reaming until good cortical chatter was obtained. A stem was then selected of the same diameter as the final reamer. A press-fit was achieved by impacting the stem into the canal.
Data was gathered through review of the electronic and physical patient records and radiographs. All radiographs were interpreted by a single observer (M.J.W.). Information regarding patient age, sex, diagnosis, previous surgery or reconstruction, type and location of implant, adjuvant therapy such as chemotherapy or radiation, postoperative complications and re-operations, loosening, and implant failure were documented. A stage was assigned to malignant tumors based upon the Musculoskeletal Tumor Society (MSTS) staging system. 29 The Social Security Death Index (SSDI) was used to confirm mortality.
The primary outcome was considered to be implant failure; this was defined as failure leading to re-operation. Secondary outcome variables included loosening, patient survival, and deep infection. Loosening was defined as implant subsidence or a contiguous radiolucent line on plain radiographs around the entire perimeter of the cementless stem. Deep infection included any infection that required operative debridement or any patient with positive cultures after joint aspiration.
Data was compiled and statistical analysis was performed using Microsoft Excel (Microsoft, Redmond, WA) and Sigma Stat 3.5 (Systat, San Jose CA). Kaplan-Meier survival curves were constructed to demonstrate implant longevity and overall patient survival. The Fisher exact test was used to determine if history of a previous reconstructive surgery, perioperative chemotherapy, age, sex, diagnosis of malignancy, or anatomic location were associated with implant failure. Statistical significance was defined as a Pr0.05.
Thirty-seven cementless modular endoprosthetic stems were implanted in 37 patients (Table 1) . Mean follow-up was 23 months ( ± 15 month). One patient underwent reconstruction using both distal femoral and proximal tibial components, which was considered a unique anatomic site for the purposes of analysis. That is, although it has two stems, the distal femoral or proximal tibial implant likely has different biomechanical characteristics than either a distal femoral or proximal tibial implant, and so it was included in its own category anatomically and considered for the purposes of analysis as a single implant. Median patient age at the time of surgery was 38 years (range, 9-81 year) . Seventy percent of patients were male. Eighty-four percent of patients (31) underwent reconstruction after resection of a malignant tumor. Twenty-two distal femoral, 12 proximal tibial, two proximal femoral, and one combination of distal femoral and proximal tibial stems were implanted ( Table 2) . Ninety-two percent of patients (34 of 37) underwent primary reconstruction after a tumor resection, while 8% (three of 37) had a failed previous reconstructive procedure that was being revised. Table 1 . In the cohort of 37 patients, there were three failures that required revision, yielding a Kaplan-Meier estimated implant survival of 89% at 4 years ( Figure 2 ). There were two cases of septic loosening and one case of failure of bone ingrowth that led to revision. There were no periprosthetic fractures or direct implant failures or breakage in our series. None of these complications were in the dual implant patient.
RESULTS

Patient demographics are listed in
The Fisher exact test demonstrated that a previous reconstructive procedure (P ¼ 1.0), male gender (P ¼ 0.21), perioperative chemotherapy (P ¼ 1.0), age greater than 37 (P ¼ 0.23), diagnosis of a malignancy (P ¼ 1.0), and anatomic location (P ¼ 1.0) did not predict failure. Kaplan-Meier estimated patient survival was 78% at 4 years (Figure 3 ).
DISCUSSION
Zeegan et al., 21 in a recent review of cemented modular endoprostheses, reported 88% and 76% survivorship at 3 years and 5 years, respectively. The patients studied in that series were treated by the same operating surgeons as the cementless implants and had similar outcomes. Similar results have been reported by numerous other authors, with a 3-year failure rate of 82--91%. 15,24,30--32 Our results with cementless prostheses are similar to these short-term results with cemented implants. Earlier generations of cementless modular endoprostheses had an unacceptably high failure rate from implant breakage. 11, 28 In our series, there were no direct implant failures. This may reflect advances in component design, metallurgy, and manufacturing processes. Figure 4 demonstrates the preoperative and postoperative radiographs of a typical patient treated with a cementless modular megaprosthesis. This patient was a 45-year-old woman who presented with a high-grade, extracompartmental osteosarcoma of her left distal femur. Preoperatively she received chemotherapy. The tumor was resected, and a cementless stem and modular megaprosthesis were used to reconstruct her distal femur. Her postoperative course was uncomplicated. Initial radiographs revealed the components to be well seated and the cementless stem filling the medullary canal. Routine follow-up films at 3 years show the components to be well placed without signs of loosening. The diaphyseal bone appears to have remodeled and hypertrophied at the region of the bone-implant interface. At 3.5 years she succumbed to metastatic disease.
While the experience with cementless fixation in the arthroplasty literature has been generally positive, the effects of adjuvant therapy on the biologic response of the host bone to cementless implants in sarcoma or cancer patients is unknown. Chemotherapy and radiation likely retard the healing process and may affect the overall strength and quality of the implant-bone interface. Our study was not designed to study the effect of chemotherapy, and we have avoided using cementless stems in patients undergoing radiation treatment.
While this is a small cohort, and long-term outcome data are not yet available, cementless modular endoprostheses appear to have a promising role in the treatment of large osseous defects of the lower extremity, and their use may be appropriate in a select group of patients. Our decision to use cementless fixation was dependent upon many variables including diagnosis, prognosis, bone quality, adjuvant therapy (particularly radiation therapy), and surgeon experience. We conclude that the use of cementless stems in endoprosthetic reconstruction of large osseous defects of the lower extremity is associated with a similar short-term failure rate when compared with implants that rely on cemented fixation.
The optimal patient population for treatment with both cemented and cementless stem fixation remains unclear. There is likely a subset of patients who may not benefit from the use of cementless implants. Further study and long-term findings may yield more information, allowing specific recommendations to be made about which patient groups are most appropriate for cementless fixation. 
